Publié 31 Oct. 2024
Willing to unlock the full value of your oncology innovation?
Apply before October 31st!
When applying to the MATWIN accelerating program, you will:
- Assess and increase the potential of your project in the discovery / preclinical development phase
- Obtain validation guidelines for your development plan (clinical route, indications, milestones, regulatory guidance etc.) from MATWIN International Board), experts in the field and KOLs
- Get ready for the investment phase thanks to numerous individual high value added-value coaching sessions
- Optimize your partnership opportunities with biotechs / pharmas / investors
ELIGIBILITY
- Open to European academic teams or start-ups
- Preclinical or early clinical stages with validated POC and defined PI background
- R&D oncology focused projects in therapeutic, diagnostic, medical device, technological platform, AI tools
Contact MATWIN for more information at contact@matwin.fr